BMPR2 and idiopathic pulmonary arterial hypertension: In humans, aberrant immune regulation is a key feature in a significant proportion of patients with IPAH and associated with clinical outcomes, with a small subset of patients showing immunoglobin reactivity to BMPRII [40].